title: [Cancer of the pancreas].
abstract: The incidence of pancreatic cancer is increasing but the prognosis remains poor. The lack of clearly identified risk factors hinders screening and early diagnosis (when the disease is still curable). The sole curative treatment is surgical resection, which is feasible in only 15% of patients. Chemotherapy regimens are being developed in an attempt to prolong the survival of patients who do not quality for surgery. Recent advances include better knowledge and treatment of pre-neoplastic pancreatic lesions such as mucinous tumors. Basic and translational researchers are attempting to identify tumoral or circulating antigens that could serve as diagnostic markers and/or therapeutic targets.
authors.affiliation: Gastro-enttrologie et Nutrition, INSERM UMR 1037, Centre de Recherche Contre le Cancer de Toulouse CHU Rangueil-Toulouse. Buscail.L@chu-toulouse.fr
authors.forename: Louis
authors.initials: L
authors.lastname: Buscail
authors.forename: Barbara
authors.initials: B
authors.lastname: Bournet
authors.forename: Pierre
authors.initials: P
authors.lastname: Cordelier
mesh_terms: D055088:Early Detection of Cancer / Q000379:methods; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011230:Precancerous Conditions / Q000175:diagnosis; D011379:Prognosis
vernacular_title: Le cancer du pancréas.